Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Affymetrix Inc (AFFX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 1,129,940
  • Shares Outstanding, K 80,490
  • Annual Sales, $ 359,790 K
  • Annual Income, $ 10,110 K
  • 36-Month Beta 0.20
  • Price/Sales 1.59
  • Price/Cash Flow 6.25
  • Price/Book 3.32
  • Price/Earnings ttm 34.12
  • Earnings Per Share ttm 0.41
  • Most Recent Earnings 0.10 on 10/28/15
  • Next Earnings Date 05/04/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.97 +0.29%
on 03/03/16
16.15 -13.25%
on 03/18/16
-0.03 (-0.21%)
since 02/29/16
3-Month
9.17 +52.78%
on 01/08/16
16.15 -13.25%
on 03/18/16
+4.02 (+40.24%)
since 12/29/15
52-Week
8.28 +69.20%
on 10/06/15
16.15 -13.25%
on 03/18/16
+1.30 (+10.23%)
since 03/27/15

Most Recent Stories

More News
Global Cancer Biomarker Market 2014-2025 by Analysis of Type, Biomolecule, By Application, And Segment Forecasts

Research and Markets has announced the addition of the "Cancer Biomarker Market Analysis By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic,...

A : 61.37 (+0.64%)
HOLX : 45.01 (-0.88%)
ABT : 50.84 (-0.02%)
ILMN : 172.75 (+0.45%)
MRK : 62.63 (-0.49%)
AFFX : 14.01 (+0.14%)
48.1% Return Seen to Date on SmarTrend Affymetrix Call (AFFX)

SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 20 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.

AFFX : 14.01 (+0.14%)
Uptrend Call Working As Affymetrix Stock Rises 48.1% (AFFX)

SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 19 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.

AFFX : 14.01 (+0.14%)
Affymetrix Up 48.1% Since SmarTrend Uptrend Call (AFFX)

SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 19 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.

AFFX : 14.01 (+0.14%)
Affymetrix Has Returned 48.1% Since SmarTrend Recommendation (AFFX)

SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 19 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.

AFFX : 14.01 (+0.14%)
Worldwide Biochips Market: To Beat Competition, Keen Players Leverage Latest Technologies for Product Development, Finds TMR

ALBANY, New York, May 16, 2017 /PRNewswire/ --

ILMN : 172.75 (+0.45%)
AFFX : 14.01 (+0.14%)
Worldwide Biochips Market: To Beat Competition, Keen Players Leverage Latest Technologies for Product Development, Finds TMR

The global market for biochips is partially consolidated in which the top four players account for just under half the market share. Affymetrix Inc. is the dominant player and accounted for 15.7% of the...

A : 61.37 (+0.64%)
ILMN : 172.75 (+0.45%)
AFFX : 14.01 (+0.14%)
Shares of AFFX Up 48.1% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 18 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.

AFFX : 14.01 (+0.14%)
48.1% Return Seen to Date on SmarTrend Affymetrix Call (AFFX)

SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 18 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.

AFFX : 14.01 (+0.14%)
Shares of AFFX Up 48.1% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 28th, 2015 at $9.46. In approximately 18 months, Affymetrix has returned 48.10% as of today's recent price of $14.01.

AFFX : 14.01 (+0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Affymetrix scientists invented the world's first high-density microarray and began selling the first commercial microarray. Since then, Affymetrix GeneChip technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world's top pharmaceutical, diagnostic...

See More

Support & Resistance

2nd Resistance Point 14.07
1st Resistance Point 14.04
Last Price 14.01
1st Support Level 13.99
2nd Support Level 13.97

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.